April 7, 2023Open Access

TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Compared with TACE alone, combination therapy was safe enough and resulted in survival benefits. This is a promising treatment option for HCC patients with PVTT.

Me gusta

Guardar

Ver artículo completo